TRACE: Transformer-based Risk Assessment for Clinical Evaluation

Dionysis Christopoulos,Sotiris Spanos,Valsamis Ntouskos,Konstantinos Karantzalos

2024-11-13

Abstract:We present TRACE (Transformer-based Risk Assessment for Clinical Evaluation), a novel method for clinical risk assessment based on clinical data, leveraging the self-attention mechanism for enhanced feature interaction and result interpretation. Our approach is able to handle different data modalities, including continuous, categorical and multiple-choice (checkbox) attributes. The proposed architecture features a shared representation of the clinical data obtained by integrating specialized embeddings of each data modality, enabling the detection of high-risk individuals using Transformer encoder layers. To assess the effectiveness of the proposed method, a strong baseline based on non-negative multi-layer perceptrons (MLPs) is introduced. The proposed method outperforms various baselines widely used in the domain of clinical risk assessment, while effectively handling missing values. In terms of explainability, our Transformer-based method offers easily interpretable results via attention weights, further enhancing the clinicians' decision-making process.

Computer Vision and Pattern Recognition,Artificial Intelligence,Machine Learning

What problem does this paper attempt to address?

### What problems does this paper attempt to solve?

This paper aims to solve several key problems in clinical risk assessment:

1. **Multimodal data processing**:
- Clinical data usually contains multiple types of data, such as continuous data (e.g., age, height, weight), categorical data (e.g., eye color, hair color), and checkbox - type data (e.g., ancestry, doctors visited, etc.). These different types of data are difficult to be processed uniformly in traditional methods.
- The paper proposes a Transformer - based framework named TRACE (Transformer - based Risk Assessment for Clinical Evaluation), which can effectively process these different - modal data.

2. **Missing value handling**:
- Clinical data often has missing values, which will affect the performance and reliability of the model. Existing methods usually handle this problem by filling or deleting missing values, but these methods may introduce bias or lose information.
- The TRACE model explicitly handles missing values. For continuous data, it adopts a weight - mask mechanism, and for categorical and checkbox - type data, it defines special embedding tokens to ignore missing items.

3. **Interpretability**:
- In the medical field, the interpretability of the model is crucial. Doctors need to understand the decision - making process of the model in order to make better diagnosis and treatment decisions.
- The TRACE model provides interpretable results by generating attention maps, making it easier for doctors to understand the basis of the model's predictions.

4. **Class imbalance problem**:
- In clinical data, the case group (i.e., the diseased group) is usually much smaller than the control group (i.e., the non - diseased group), which will cause the model to tend to predict the majority class, thus reducing the recognition ability of the minority class.
- The paper uses Focal Loss to solve the class imbalance problem. By adjusting the hyper - parameter α, the model pays more attention to hard cases (e.g., false negatives), thus improving the recognition ability of the minority class.

5. **Performance improvement**:
- Existing clinical risk assessment methods have limited performance when dealing with complex data. The TRACE model not only performs well on multiple benchmark datasets, but also has advantages in handling missing values and class imbalance problems.
- Experimental results show that the TRACE model is superior to existing methods in multiple evaluation metrics such as accuracy, F1 - Score, sensitivity, and specificity.

In summary, by proposing the TRACE model, this paper solves the problems of multimodal data processing, missing value handling, interpretability, and class imbalance in clinical risk assessment, providing clinicians with a more reliable and interpretable risk assessment tool.